A novel strategy to reduce the readmission rates in congestive heart failure : intermittent empirical intravenous diuretics
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved..
Improvements in the medical management of heart failure have changed the course of the disease. However, mortality rates, hospitalization rates, and treatment costs are not at desired levels. Diuretics have been widely used in the treatment of congestion in heart failure patients. The following case reports represent a special patient group treated and followed by cardiology clinic. Treatment approach of each case report has been tailored on an individual basis depending on the clinical course and hospitalization rates of patients. Authors have highlighted and discussed the common aspects and future perspectives of their cases in which post-discharge intermittent empirical intravenous diuretic administration dramatically improved the clinical status and readmission number due to decompensated congestive heart failure. This is a relatively new and promising approach, which has been thought to cease the recycle of diuretic resistance and silent increase of fluid congestion in patients with congestive heart failure and frequent hospitalization.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Cardiovascular endocrinology & metabolism - 9(2020), 2 vom: 01. Juni, Seite 60-63 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yetkin, Ertan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Case Reports |
|---|
| Anmerkungen: |
Date Revised 28.09.2020 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1097/XCE.0000000000000200 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311166660 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311166660 | ||
| 003 | DE-627 | ||
| 005 | 20231225141657.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/XCE.0000000000000200 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1037.xml |
| 035 | |a (DE-627)NLM311166660 | ||
| 035 | |a (NLM)32537567 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yetkin, Ertan |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A novel strategy to reduce the readmission rates in congestive heart failure |b intermittent empirical intravenous diuretics |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 28.09.2020 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. | ||
| 520 | |a Improvements in the medical management of heart failure have changed the course of the disease. However, mortality rates, hospitalization rates, and treatment costs are not at desired levels. Diuretics have been widely used in the treatment of congestion in heart failure patients. The following case reports represent a special patient group treated and followed by cardiology clinic. Treatment approach of each case report has been tailored on an individual basis depending on the clinical course and hospitalization rates of patients. Authors have highlighted and discussed the common aspects and future perspectives of their cases in which post-discharge intermittent empirical intravenous diuretic administration dramatically improved the clinical status and readmission number due to decompensated congestive heart failure. This is a relatively new and promising approach, which has been thought to cease the recycle of diuretic resistance and silent increase of fluid congestion in patients with congestive heart failure and frequent hospitalization | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a diuretic therapy | |
| 650 | 4 | |a furosemide | |
| 650 | 4 | |a heart failure | |
| 650 | 4 | |a hospitalization | |
| 650 | 4 | |a intermittent | |
| 700 | 1 | |a Cuglan, Bilal |e verfasserin |4 aut | |
| 700 | 1 | |a Turhan, Hasan |e verfasserin |4 aut | |
| 700 | 1 | |a Ozturk, Selcuk |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiovascular endocrinology & metabolism |d 2018 |g 9(2020), 2 vom: 01. Juni, Seite 60-63 |w (DE-627)NLM295294205 |x 2574-0954 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2020 |g number:2 |g day:01 |g month:06 |g pages:60-63 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/XCE.0000000000000200 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2020 |e 2 |b 01 |c 06 |h 60-63 | ||